PACTR202607713053712Active, not recruitingNot Applicable
Assessing effectiveness of methods of providing information to parents on children’s oral Hygiene - Randomized Control Field Trial in Ubungo, Tanzania
Muhimbili University of Health and Allied Sciences0 sites120 target enrollmentStarted: September 20, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Enrollment
- 120
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 2 Year(s) to 5 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •The inclusion criteria are as follows:
- •Children with the ability to comprehend and follow instructions
- •Parents of children aged 4 – 6 years consenting to participate in the study
- •Reassurance to stay in the study area for the study duration
Exclusion Criteria
- •? Parents/guardians without mobile
- •? Unable to provide an alternative contact mobile number
- •? Children living without their parents
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Evaluating the effect of an oral hygiene kit versus verbal and written instructions in enhancing compliance among childrenCTRI/2026/07/113413Vedanti Kulkarni120
Active, not recruiting
Not Applicable
Preventing Sore Throat After Surgery by administering Intracuff and Nebulized KetamineCTRI/2026/07/113470Shri Ram Murti Smarak Institute of Medical Sciences94
Recruiting
Phase 1
An exploratory study to investigate the effect of FE 999302 when given together with follitropin delta during controlled ovarian stimulation2023-507630-25-00Ferring Pharmaceuticals A/S600
Recruiting
Not Applicable
Evaluation of efficacy of bicalutamide mesotherapy treatment in women with female pattern hair loss at a tertiary care centre.CTRI/2026/07/113261Department of Dermatology,Sion Hospital30
Not yet recruiting
Not Applicable
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared with Placebo in Adults with Type 2 Diabetes Mellitus on
Background Insulin (Eluminate-3)Type 2 Diabetes MellitusjRCT203126026280